Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.
Animals
Fungal Proteins
/ metabolism
Lectins, C-Type
/ genetics
Macrophages
/ immunology
Membrane Glycoproteins
/ metabolism
Mice
Pneumocystis
/ immunology
Pneumocystis carinii
/ immunology
Pneumonia, Pneumocystis
/ immunology
RAW 264.7 Cells
RNA, Messenger
/ genetics
Saccharomyces cerevisiae
/ immunology
Tumor Necrosis Factor-alpha
/ metabolism
beta-Glucans
/ immunology
Pneumocystis
Msg
MCL
Mincle
major surface glycoprotein
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
21
11
2019
accepted:
24
04
2020
pubmed:
5
5
2020
medline:
5
3
2021
entrez:
5
5
2020
Statut:
ppublish
Résumé
Pneumocystis major surface glycoprotein (Msg) is a 120-kD surface protein complex on the organism with importance in adhesion and immune recognition. In this study, we show that Msg significantly impairs tumor necrosis factor (TNF)-α secretion by macrophages induced by Saccharomyces cerevisiae and Pneumocystis carinii (Pc) β-glucans. Major surface glycoprotein was shown to greatly reduce β-glucan-induced Dectin-1 immunoreceptor tyrosine-based activating motif (ITAM) phosphorylation. Major surface glycoprotein also down regulated Dectin-1 receptor messenger ribonucleic acid (mRNA) expression in the macrophages. It is interesting that Msg incubation with macrophages resulted in significant mRNA upregulation of both C-type lectin receptors (CLR) Mincle and MCL in Msg protein presence alone but to even greater amounts in the presence of Pc β-glucan. The silencing of MCL and Mincle resulted in TNF-α secretions similar to that of macrophages treated with Pneumocystis β-glucan alone, which is suggestive of an inhibitory role for these 2 CLRs in Msg-suppressive effects on host cell immune response. Taken together, these data indicate that the Pneumocystis Msg surface protein complex can act to suppress host macrophage inflammatory responses to the proinflammatory β -glucan components of the organisms.
Sections du résumé
BACKGROUND
Pneumocystis major surface glycoprotein (Msg) is a 120-kD surface protein complex on the organism with importance in adhesion and immune recognition. In this study, we show that Msg significantly impairs tumor necrosis factor (TNF)-α secretion by macrophages induced by Saccharomyces cerevisiae and Pneumocystis carinii (Pc) β-glucans.
METHODS
Major surface glycoprotein was shown to greatly reduce β-glucan-induced Dectin-1 immunoreceptor tyrosine-based activating motif (ITAM) phosphorylation. Major surface glycoprotein also down regulated Dectin-1 receptor messenger ribonucleic acid (mRNA) expression in the macrophages. It is interesting that Msg incubation with macrophages resulted in significant mRNA upregulation of both C-type lectin receptors (CLR) Mincle and MCL in Msg protein presence alone but to even greater amounts in the presence of Pc β-glucan.
RESULTS
The silencing of MCL and Mincle resulted in TNF-α secretions similar to that of macrophages treated with Pneumocystis β-glucan alone, which is suggestive of an inhibitory role for these 2 CLRs in Msg-suppressive effects on host cell immune response.
CONCLUSIONS
Taken together, these data indicate that the Pneumocystis Msg surface protein complex can act to suppress host macrophage inflammatory responses to the proinflammatory β -glucan components of the organisms.
Identifiants
pubmed: 32363390
pii: 5828589
doi: 10.1093/infdis/jiaa218
pmc: PMC7459132
doi:
Substances chimiques
Fungal Proteins
0
Lectins, C-Type
0
Membrane Glycoproteins
0
RNA, Messenger
0
Tumor Necrosis Factor-alpha
0
beta-Glucans
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1213-1221Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL062150
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Blood. 2005 Oct 1;106(7):2543-50
pubmed: 15956283
Nat Immunol. 2007 Jan;8(1):39-46
pubmed: 17159982
Am J Respir Cell Mol Biol. 2012 Jul;47(1):50-9
pubmed: 22343219
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
J Immunol. 2006 Jul 1;177(1):459-67
pubmed: 16785543
J Immunol. 2000 Apr 1;164(7):3755-63
pubmed: 10725735
J Immunol. 1993 May 1;150(9):3932-40
pubmed: 8386203
Front Immunol. 2018 Feb 13;9:213
pubmed: 29487596
Med Mycol. 2018 Nov 1;56(8):994-1005
pubmed: 29267980
Infect Immun. 2004 Jun;72(6):3147-60
pubmed: 15155616
J Eukaryot Microbiol. 2001;Suppl:157S
pubmed: 11906040
Infect Immun. 2015 Feb;83(2):671-81
pubmed: 25422263
Am J Respir Cell Mol Biol. 2018 Feb;58(2):232-240
pubmed: 28886250
J Biol Chem. 2003 Jul 4;278(27):25001-8
pubmed: 12716885
J Immunol. 2007 Mar 15;178(6):3702-12
pubmed: 17339468
Front Immunol. 2018 Apr 16;9:673
pubmed: 29755450
Am J Physiol Lung Cell Mol Physiol. 2010 Feb;298(2):L252-60
pubmed: 19915161
PLoS Pathog. 2008 Dec;4(12):e1000227
pubmed: 19057660
J Biol Chem. 2003 Jan 17;278(3):2043-50
pubmed: 12419803
AIDS. 2003 Jan 3;17(1):73-80
pubmed: 12478071
Am J Respir Cell Mol Biol. 2001 Apr;24(4):475-84
pubmed: 11306442
J Biomol Screen. 2009 Feb;14(2):151-60
pubmed: 19196705
Cell Rep. 2018 Jan 30;22(5):1288-1300
pubmed: 29386115
Pulmonology. 2019 Sep - Oct;25(5):271-274
pubmed: 31076291
J Infect Dis. 2018 Oct 5;218(10):1631-1640
pubmed: 29868908
Infect Immun. 2017 Sep 20;85(10):
pubmed: 28694293
Immunity. 2013 Aug 22;39(2):324-34
pubmed: 23911656
Am J Respir Cell Mol Biol. 2000 Jun;22(6):722-31
pubmed: 10837370
J Infect Dis. 2016 Sep 1;214(5):782-91
pubmed: 27324243
Infect Immun. 2015 Jul;83(7):2816-26
pubmed: 25916991
J Immunol. 2017 May 1;198(9):3515-3525
pubmed: 28298521
J Biol Chem. 1993 Mar 15;268(8):6034-40
pubmed: 8449961
Front Immunol. 2018 Apr 26;9:804
pubmed: 29755458
J Immunol. 2015 Jun 1;194(11):5366-74
pubmed: 25888641
Infect Immun. 2005 Oct;73(10):6340-9
pubmed: 16177305
J Clin Invest. 1991 Jan;87(1):163-70
pubmed: 1985093
J Clin Invest. 1997 May 1;99(9):2110-7
pubmed: 9151783
Infect Immun. 2016 Aug 29;84(11):3195-3205
pubmed: 27572330